Zhejiang Wolwo Bio-Pharmaceutical Balance Sheet Health
Financial Health criteria checks 5/6
Zhejiang Wolwo Bio-Pharmaceutical has a total shareholder equity of CN¥2.4B and total debt of CN¥44.4M, which brings its debt-to-equity ratio to 1.9%. Its total assets and total liabilities are CN¥2.7B and CN¥326.8M respectively. Zhejiang Wolwo Bio-Pharmaceutical's EBIT is CN¥309.2M making its interest coverage ratio -10.2. It has cash and short-term investments of CN¥1.3B.
Key information
1.9%
Debt to equity ratio
CN¥44.37m
Debt
| Interest coverage ratio | -10.2x |
| Cash | CN¥1.32b |
| Equity | CN¥2.35b |
| Total liabilities | CN¥326.77m |
| Total assets | CN¥2.68b |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: 300357's short term assets (CN¥1.6B) exceed its short term liabilities (CN¥248.6M).
Long Term Liabilities: 300357's short term assets (CN¥1.6B) exceed its long term liabilities (CN¥78.1M).
Debt to Equity History and Analysis
Debt Level: 300357 has more cash than its total debt.
Reducing Debt: 300357's debt to equity ratio has increased from 0% to 1.9% over the past 5 years.
Debt Coverage: 300357's debt is well covered by operating cash flow (722%).
Interest Coverage: 300357 earns more interest than it pays, so coverage of interest payments is not a concern.